ID: glutathione
Aliases: GSH, reduced glutathione, IV glutathione
Type: compound
Route/form: oral/topical/IV depending context; IV wellness use is compounded/off-label
Status: supplement_or_compounded
Evidence level: human RCT
Best data tier: human controlled/review; exact-use indirect
Support scope: human
Source types: systematic_review
Linked sources: 2
Broad outcomes: Gut / immune / inflammation, Longevity / mitochondrial / redox, Skin / wound repair
Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.
Targets / mechanism
- redox buffering
- glutathione peroxidase/reductase system
- melanin/skin-pigment pathways in dermatology claims
Optimization domains
- redox
- skin
- liver
- detox claims
- mitochondrial
Research basis
- Human dermatology evidence exists for systemic glutathione skin-color endpoints.
- Mechanistically central to cellular redox biology and antioxidant recycling.
Limits, risks, and missing evidence
- Skin-lightening data do not validate broad detox, longevity, or performance claims.
Risk flags
- route specific evidence
- skin lightening context
- iv compounding risk
- claims often overextended
Linked papers, labels, and reviews
- The clinical effect of glutathione on skin color and other related skin conditions: a systematic review
systematic_review / pubmed_glutathione_skin_systematic_review_2019
Human skin-lightening/skin endpoints; not a global detox or anti-aging proof. - Systemic glutathione as a skin-whitening agent in adult
systematic_review / pubmed_glutathione_skin_systemic_2020
Systemic glutathione dermatology evidence synthesis with safety caveats.